AHA letter expressing support for the Helping Medicaid Offer Maternity Services Act (H.R.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
AHA letter to CMS regarding their attention to improving health plan prior authorization processes through appropriate standardization.
AHA urges the Centers for Medicare & Medicaid Services to release long-awaited guidance to help hospitals and health systems interpret Medicare’s conditions of participation, or develop alternative approaches to keep them informed and updated about compliance.
AHA letter to the Congressional Telehealth Caucus in support of the CONNECT for Health Act of 2019.
The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of
AHA's comments to House leaders on the Lower Drug Costs Now Act (H.R. 3), legislation that would make a series of changes to the Medicare program in an effort to lower the price of prescription drugs.
The AHA recognizes that SAMHSA is statutorily constrained in making structural amendments to the regulations under 42 CFR Part 2; however, because the proposed rule would not chan
The AHA urges Senate appropriators to support federal funding for research and education to reduce violence in communities
The AHA and six other organizations comments to the Drug Enforcement Administration on its proposed rule regarding controlled substances quotas.